基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 原料药 血液系统用药 血容量扩充剂 葡聚糖 右旋糖酐40
  • 右旋糖酐40

右旋糖酐40

Dextran40
9004-54-0
陕西 更新日期:2018-07-24

XI’AN WANLONG PHARMACEUTICAL CO.,LTD

非会员
联系人:raffia chou
电话:029-81881044拨打
手机:13259794374 拨打
邮箱:raffiachou@hotmail.com

产品详情:

中文名称:
右旋糖酐40
英文名称:
Dextran40
CAS号:
9004-54-0
产地:
陕西、西安
纯度规格:
≥99%

 

CAS: 9004-54-0

MF: [C6H10O5]n

EINECS:232-677-5

Grade: injection,   EP6.0 standard

Dextranum; Plavoles;in-tradex; Gentran;Polyglucino Mucrose

clinical injection, synthesize dextran gel and other important derivatives; plasma volume expander, improve the microcirculation, keep blood from bolting formation and benefit urine function; Cure to use the film layer

 

Molecular weight: 35000~45000

Molecular weight : M10 110000

Distribution: M90 7000

Solubility: Very soluble in water, very slightly in alcohol, Clear and colorless solution

Appearance: White powder

Solubility: Very soluble in water and slightly soluble in alcohol.

Package: 25Kg/drum

Benefit: Dextran 40 is primarily used in the medical industries for its abilities to moderate blood viscosity and decrease vascular thrombosis. Other uses include acting as a lubricant in eye drop products and advancing microcirculation within the body.

Dextran40;API;avtive pharmaceutical ingredients

公司简介

Xi’an Wanlong pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates. The company’s registered capital reaches CNY 75 million. The building area of company is over 2000000 square meters. All the work shops are compliant with GMP requirements. There are more than 700 employees including over 70 RD staffs,20 experienced production management people and 8 senior professional registration specialists. Having a dynamic, high-quality team, which ensures our company sustainable and stable development. We produce tablets, capsule, granules, injection and API, total 49 drug approval numbers and other intermediates. There are 4 API workshops, and two solid preparation plants, injection plants with GMP. Annual production capacity of 100 tons of raw material, solid dosage form annual output of 3 billion, injection annual output 1.3 billion bags. The drug products are widely used in the most

成立日期 (30年)
注册资本 7500.000000万
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂
主营行业 医药中间体,原料药

右旋糖酐40相关厂家报价 更多

  • 右旋糖酐
  • 右旋糖酐
  • 河南沃咖斯生物科技有限公司 VIP
  • 2025-01-05
  • 询价
  • 右旋糖酐
  • 右旋糖酐
  • 湖北鸿福达生物科技有限公司 VIP
  • 2025-01-05
  • 询价
  • 葡聚糖T9
  • 葡聚糖T9
  • 上海弘顺生物科技有限公司 VIP
  • 2025-01-05
  • ¥80
内容声明
拨打电话 立即询价